Home › Funds › Duquesne Family Office LLC › RVMD
Duquesne Family Office LLC position in RVMD
REVOLUTION MEDICINES INC · Health Care
Duquesne Family Office LLC reported holding 436,287 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$89.6M, representing 2.38% of its reported portfolio and ranking #9 among its reported holdings. Duquesne Family Office LLC has disclosed RVMD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Duquesne Family Office LLC's RVMD position evolved
Duquesne Family Office LLC first disclosed a stake in RVMD in Q1 2026 at 315,860 shares (US$30.7M). The position peaked in Q3 2026 at 436,287 shares, worth US$89.6M. Across 3 filings, Duquesne Family Office LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 436,287 shares valued at US$89.6M — an increase of 36,700 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 315.86K | $30.72M | New |
| Q2 2026 | 399.59K | $74.83M | Add |
| Q3 2026 | 436.29K | $89.55M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 53 other funds we track also report a position in RVMD — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.75B), Farallon Capital Management (US$2.54B), BAKER BROS. ADVISORS LP (US$2.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.42M sh · $2.75B · Q3 2026
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 10.64M sh · $2.18B · Q3 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.18B · Q3 2026
- Nextech Invest Ltd. 7.60M sh · $1.56B · Q3 2026
- Janus Henderson Group 7.57M sh · $1.56B · Q3 2026
- Paradigm Biocapital Advisors LP 6.22M sh · $1.28B · Q3 2026
- Alphabet Inc. 2.67M sh · $548.85M · Q3 2026
- Casdin Capital 2.58M sh · $529.02M · Q3 2026
- BVF INC/IL 2.46M sh · $505.05M · Q3 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.15M sh · $440.28M · Q3 2026
More on Duquesne Family Office LLC
FAQ
How long has Duquesne Family Office LLC held RVMD?
Duquesne Family Office LLC has disclosed RVMD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Duquesne Family Office LLC's current position in RVMD?
As of Q3 2026, Duquesne Family Office LLC holds 436.29K shares of RVMD (REVOLUTION MEDICINES INC), valued at $89.55M, representing 2.38% of its reported portfolio and ranking #9.
Has Duquesne Family Office LLC been buying or selling RVMD?
In the latest 13F filing (Q3 2026), Duquesne Family Office LLC increased its position in RVMD. The position peaked in Q3 2026 at 436.29K shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, BAKER BROS. ADVISORS LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.